Incyte Pins Hopes On Phase III Jakafi Analysis In COVID-19 ARDS
Phase III Overall Negative, But Successful On Subset And Post-Hoc Analyses
Incyte hopes to gain an expanded access protocol for Jakafi in patients with COVID-19-associated ARDS • Source: Shutterstock